Kota Sunil Kumar, Modi Kirtikumar, Kumaresan Karuppiah
Department of Endocrinology, Medwin Hospital, Hyderabad, India.
Indian J Endocrinol Metab. 2011 Jul;15(Suppl 2):S138-40. doi: 10.4103/2230-8210.83355.
Dyshormonogenesis is an uncommon cause of congenital hypothyroidism. The most common abnormality is absent or insufficient thyroid peroxidase enzyme. Maternal intake of antithyroid drug can also lead to elevated thyroid stimulating hormone (TSH) in a neonate, albeit the scenario is temporary. We report one such interesting case where a clinically euthyroid neonate borne to a mother on antithyroid drug presents on 12(th) day of life with reports of elevated TSH and increased tracer uptake in 99mTc thyroid scan. Disproportionately high TSH in comparison to low maternal antithyroid drug dosage and further elevation of TSH after stopping mother's antithyroid drugs ruled out maternal antithyroid drug-induced congenital hypothyroidism in the baby. Early institution of therapy in these patients can prevent mental retardation and other features of hypothyroidism.
激素合成障碍是先天性甲状腺功能减退症的一种罕见病因。最常见的异常是甲状腺过氧化物酶缺乏或不足。母亲摄入抗甲状腺药物也可导致新生儿促甲状腺激素(TSH)升高,不过这种情况是暂时的。我们报告了这样一个有趣的病例,一名母亲服用抗甲状腺药物的临床甲状腺功能正常的新生儿在出生后第12天出现TSH升高,且99mTc甲状腺扫描显示示踪剂摄取增加。与母亲低剂量抗甲状腺药物相比,TSH升高不成比例,且在停用母亲的抗甲状腺药物后TSH进一步升高,排除了婴儿母亲抗甲状腺药物所致先天性甲状腺功能减退症。对这些患者早期进行治疗可预防智力发育迟缓及甲状腺功能减退的其他特征。